List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 555 studies with search of: Multiple Sclerosis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon-1beta (Betaseron, BAY86-5046)
2 Not yet recruiting Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Relapsing Remitting Multiple Sclerosis
Conditions: Multiple Sclerosis;   Vitamin D Deficiency
Intervention: Dietary Supplement: Cholecalciferol
3 Completed Auditory Function in Patients With and Without Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Hearing in Multiple Sclerosis
4 Recruiting Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Serum antibodies to infectious agents using the BioPlex 2200 and complementary EIA kits
5 Active, not recruiting Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Conditions: Multiple Sclerosis;   Optic Neuritis;   Transverse Myelitis;   Acute Brainstem/Cerebellar Syndrome
Intervention: Drug: interferon beta 1a 30 ug IM once weekly
6 Active, not recruiting Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1b and Tacrolimus
7 Completed Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta 1b;   Drug: Atorvastatin
8 Recruiting Gene Expression Profiles in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Procedure: Blood Draw
9 Active, not recruiting Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)
Condition: Multiple Sclerosis
Intervention: Procedure: MSC Treatment
10 Active, not recruiting Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Interferon beta 1-a;   Drug: glatiramer acetate;   Other: placebo
11 Active, not recruiting Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
Conditions: Multiple Sclerosis, Chronic Progressive;   Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: RTL1000 (recombinant T cell receptor ligand);   Drug: RTL1000 Placebo
12 Recruiting Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
Condition: Multiple Sclerosis, Chronic Progressive
Interventions: Drug: Cyclophosphamide (drug);   Drug: Methylprednisolone (drug)
13 Not yet recruiting Multiple Sclerosis Tailored Exercise Program
Condition: Multiple Sclerosis
Intervention: Other: Multiple Sclerosis Tailored Exercise Program
14 Terminated Study to Compare Double-Dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
15 Not yet recruiting Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Natalizumab;   Biological: Interferon B-1a;   Biological: Glatiramer acetate;   Biological: Natalizumab
16 Completed A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Intervention: Drug: Lamotrigine
17 Recruiting A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
18 Active, not recruiting 12-Week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
Condition: Multiple Sclerosis
Intervention: Drug: Rebif® New Formulation (RNF) using RebiSmartTM
19 Completed Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Daclizumab
20 Recruiting Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Condition: Multiple Sclerosis
Interventions: Drug: megadose oral methylprednisolone;   Drug: IV methylprednisolone

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services